E-LIB Suche - Ergebnisse für: Lenain, Marie-Anne

1

Pomalidomide and dexamethasone until progression after firs..:

Garderet, Laurent ; Kuhnowski, Frederique ; Berge, Benoit...
British Journal of Haematology. 201 (2023) 6 - p. 1103-1115 , 2023

Link: https://doi.org/10.1111/..

2

#5876 ISLET TRANSPLANTATION VERSUS INSULIN ALONE IN TYPE 1 ..:

Maanaoui, Mehdi ; Lenain, Rémi ; Foucher, Yohann...
Nephrology Dialysis Transplantation. 38 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

3

Correction to: Prognostic relevance of sarcopenia, geriatri..:

Pénichoux, Juliette ; Lanic, Hélène ; Thill, Caroline...
Annals of Hematology. 103 (2023) 1 - p. 369-369 , 2023

Link: https://doi.org/10.1007/..

4

High prevalence of pre-existing sarcopenia in critically il..:

Herault, Antoine ; Lévêque, Emilie ; Draye-Carbonnier, Simon...
Clinical Nutrition ESPEN. 55 (2023) - p. 373-383 , 2023

Link: https://doi.org/10.1016/..

5

Real-world study of the efficacy and safety of belantamab m..:

Talbot, Alexis ; Bobin, Arthur ; Tabone, Léa...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

6

The challenging follow-up of pregnancy in women with known ..:

Hamroun, Aghiles ; Prouteau, Camille ; Lenain, Rémi...
Journal of Nephrology. 36 (2023) 9 - p. 2519-2529 , 2023

Link: https://doi.org/10.1007/..

7

Prognostic relevance of sarcopenia, geriatric, and nutritio..:

Pénichoux, Juliette ; Lanic, Hélène ; Thill, Caroline...
Annals of Hematology. 102 (2023) 7 - p. 1811-1823 , 2023

Link: https://doi.org/10.1007/..

8

Occurrence of the endangered whitespotted eagle ray Aetobat..:

Conan, Anne ; Dennis, Michelle M. ; Gilbert, Kathleen...
Environmental Biology of Fishes. , 2023

Link: https://doi.org/10.1007/..

9

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

10

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

11

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

12

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

13

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..

14

Real-world study of the efficacy and safety of belantamab m..:

Talbot, Alexis ; Bobin, Arthur ; Tabone, Léa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543185/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566. , 2023

Link: https://u-picardie.hal.s..